Shares of Bumrungrad Hospital Public Company Limited, or BH, rose 3% after brokers forecast third-quarter 2026 profit growth and higher full-year 2026 earnings from the previous year, while recommending a buy with a target price of 232 baht. The share price this morning stood at 206.00 baht, up 6.00 baht or 3.00%, with trading value of 545.30 million baht. ASL Securities expects third-quarter 2026 revenue of 6.708 billion baht, up 3% from the same period last year. Hospital operating costs are seen at 47.5%, up from 47.0% a year earlier, due to rising physician fees and product costs, with net profit forecast at 2.063 billion baht, growing 1.4% year on year. For full-year 2026, revenue is projected at 25.879 billion baht, up 2.6%, and net profit at 7.654 billion baht, up 1.3%. The opening of Bumrungrad International Hospital Phuket is scheduled for a first-phase soft launch in the third quarter of 2027. The trend is expected to pressure short-term costs mainly from depreciation, but the gradual service rollout and centralized management should help control medical supply and administrative costs, which are variable costs, and support the creation of consistent standards.
Bumrungrad Hospital PCLBrokers recommend buy with target price 232 baht and forecast Q3 2026 profit growth.
